Palmitic acid N-hydroxysuccinimide ester

Catalog No. :
ACBIVQ970
CAS No. :
14464-31-4
Molecular Formula :
C20H35NO4
Molecular Weight :
353.50

IUPAC Name:2,5-dioxopyrrolidin-1-yl palmitate

Palmitic acid N-hydroxysuccinimide ester structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$81.00Login to see priceIn stockIn stock
25g98%$345.00Login to see priceIn stockIn stock
100g98%$1105.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePalmitic acid N-hydroxysuccinimide ester
IUPAC Name2,5-dioxopyrrolidin-1-yl palmitate
MDL No.MFCD00050402
Molecular FormulaC20H35NO4
Molecular Weight353.50
SMILESCCCCCCCCCCCCCCCC(ON1C(CCC1=O)=O)=O
InChI KeyOTNHQVHEZCBZQU-UHFFFAOYSA-N
Synonym2,5-Pyrrolidinedione, 1-[(1-oxohexadecyl)oxy]- | succinimidyl palmitate | DTXSID90404977 | AMY4566 | CS-W011850 | Palmitic acid N-hydroxysuccinimide ester, >=98% (TLC) | ZB0998 | AS-55028 | A855544 | FT-0674723 | N-palmitoyloxy-Succinimide | Hexadecanoic
CAS No.14464-31-4
PubChem CID4620598

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBIVQ970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKHRS769 route compound structure diagram
    ACKHRS7692601-98-1 In Stock
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACBIVQ970 route product structure diagram
    ACBIVQ97014464-31-4 In Stock
Inquiry

2. ACBIVQ970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPOQL635 route compound structure diagram
    ACPOQL6356066-82-6 In Stock
  4. Then
  5. ACBIVQ970 route product structure diagram
    ACBIVQ97014464-31-4 In Stock
Inquiry

Comments (0)